{"id":"NCT02230696","sponsor":"Padagis LLC","briefTitle":"Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-08","primaryCompletion":"2015-02","completion":"2015-02","firstPosted":"2014-09-03","resultsPosted":"2021-03-15","lastUpdate":"2021-10-22"},"enrollment":951,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray","otherNames":["Perrigo Product"]},{"type":"DRUG","name":"Azelastine Hydrochloride/Fluticasone Propionate Nasal Spray","otherNames":["Reference Listed Drug Product"]},{"type":"DRUG","name":"Placebo nasal spray","otherNames":[]}],"arms":[{"label":"Test Product","type":"EXPERIMENTAL"},{"label":"Reference Product","type":"ACTIVE_COMPARATOR"},{"label":"Placebo Product","type":"PLACEBO_COMPARATOR"}],"summary":"To compare safety and efficacy of Perrigo's steroid drug product compared with an FDA approved steroid drug product in the treatment of subjects with seasonal allergic rhinitis.","primaryOutcome":{"measure":"Mean Change From Baseline for Mean Reflective Total Nasal Symptom Score (rTNSS)","timeFrame":"Day 1 through Day 14","effectByArm":[{"arm":"Test Product","deltaMin":-2.95,"sd":0.15},{"arm":"Reference Product","deltaMin":-3.13,"sd":0.15},{"arm":"Placebo Nasal Spray","deltaMin":-1.98,"sd":0.19}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":30,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":381},"commonTop":[]}}